(Q42195820)

18 October 2017

title

Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis (English)

1 reference

18 October 2017

1 reference

1 reference

Lebel MH

1

1 reference

18 October 2017

Hoyt MJ

series ordinal

2

1 reference

18 October 2017

McCracken GH Jr

series ordinal

3

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

The Journal of Pediatrics

18 October 2017

published in

1 reference

18 October 2017

volume

114

1 reference

18 October 2017

issue

6

1 reference

18 October 2017

page(s)

1049-1054

1 reference

Comparison of ceftriaxone with standard therapy for bacterial meningitis

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Comparison of ceftriaxone and traditional therapy of bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Antibiotic therapy of bacterial meningitis: lessons we've learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

Current therapy of bacterial sepsis and meningitis in infants and children: a poll of directors of programs in pediatric infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

7 January 2021

Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

7 January 2021

Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

7 January 2021

Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

7 January 2021

Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980462-7

7 January 2021

10.1016/S0022-3476(89)80462-7

Identifiers

DOI

1 reference

18 October 2017

1 reference